Cuvo Health alternatives for different operating models

How should you build this shortlist?

A search for an alternative often hides two different requests: a replacement for the entire operating platform, or a replacement for one layer that no longer fits. Decide which you mean before collecting demos. If your storefront and billing already work, rebuilding them may create unnecessary disruption. If your team is struggling to coordinate separate systems, a narrower API may leave the original problem unresolved.

Use the white-label telehealth guide to separate software, clinical services and administrative operations. Then write a brief stating which components must stay, which can change and what a successful transition would look like. The following shortlist is intentionally mixed so that you can evaluate the model, not merely swap vendor names. Unknown public terms should become procurement questions rather than negative assumptions.

Which alternative fits which buying question?

The following are evaluation routes, not claims that one vendor is universally best. Public-source review date: October 22, 2026. Confirm the current written scope before contracting.

When should TEHR lead your shortlist?

TEHR fits a buyer looking for brand software, payments, subscriptions, AI-assisted intake and administrative infrastructure connected to independent clinical care. It uses a flat subscription and flat transaction fee with 0% revenue share; request a scoped quote rather than treating the structure as a complete price. Program availability and support responsibilities belong in that proposal.

The strength to evaluate is operational coordination. Ask TEHR to demonstrate a returning patient, a rebill exception and an order that needs support across teams. Its operators built DudeMeds, Peptiders, TellyMeds and FansMeds and migrated thousands of their own patients. That experience should produce a practical plan for your business, not an earnings promise. Review the platform against the tasks you want removed from your staff’s workload.

When does a practice behind an API make more sense?

Lithos positions its clinical practice behind a product the customer owns. Consider that route if you already have a differentiated application and want to keep its interface, commerce and customer relationship while evaluating a different clinical backend.

The strength is architectural separation; the tradeoff is the product and operational work you retain. Identify who maintains the integration, monitors failed events and supports the customer when the issue crosses systems. Ask whether your existing staff can own those boundaries. A practice API is not automatically a substitute for a finished brand operating environment, even if both eventually support a similar patient journey. Use the Lithos comparison to inspect the cost and implementation distinctions.

When is Beluga a useful modular alternative?

Beluga’s platform page presents multiple integration paths, including direct integration, hosted intake and platform partners. That makes it worth evaluating when you want to retain existing commerce but change the clinical infrastructure behind it.

Ask which route is actually being quoted and which patient-facing components come from another platform partner. A modular arrangement can preserve work your team has already invested in, but it requires clear responsibility at the boundaries. Obtain a diagram of intake, clinical records, pharmacy routing and patient communication. Compare the commercial terms for the selected route rather than assuming one generic Beluga price or a complete native storefront. The best fit is the route your team can operate consistently.

When does FUSE’s build model fit?

FUSE offers DIY, guided and managed implementation routes. Consider it if the ability to build and preview the brand experience matters to your team, or if you want to choose how much launch assistance you purchase.

Its merchant service fee introduces a payment-based cost component, so model your proposed orders rather than comparing subscriptions alone. The pricing page also contains an unresolved DIY monthly-price inconsistency; obtain a written quote. Ask where the build environment ends and live operational prerequisites begin. The strength is choice of implementation involvement; the tradeoff is that the cheapest-looking route may leave more setup and coordination with you. The FUSE comparison explains the fee issue.

When is Tessic’s tiered package worth evaluating?

Tessic publishes tiered platform, setup and completed-consult pricing. This gives a buyer a concrete starting structure for comparing an operated brand platform rather than assembling every component separately.

Match each required workflow to a plan before calculating cost. An entry subscription is not a reliable budget if you need integrations or multibrand features from another tier. Ask what setup delivers, which revisions are covered and how future custom work is priced. The strength is the visibility of the package structure; the tradeoff is upfront spend and possible tier dependencies. Evaluate whether the documented scope replaces real work in your organization rather than treating a larger feature list as value by itself.

When should CareValidate stay on the shortlist?

CareValidate’s launch overview describes clinical infrastructure, support and connections to pharmacy and laboratory services. Evaluate it when your operational challenge is coordinating care delivery and patient service rather than only configuring a storefront.

The strength to test is the proposed managed-service coverage. Give the team a case involving a delayed result or a patient question that moves between commercial and clinical staff. Ask who owns each action, where the status appears and what response commitments apply. Numerical pricing and revenue-share terms were not established in the reviewed material, so request an itemized schedule. Lack of public pricing is not evidence of an expensive offer; it means the commercial comparison is unfinished.

When does MD Integrations fit a Cuvo replacement?

MD Integrations describes custom API and ready-made white-label options. Consider it when the clinical service and integration path matter more than replacing every part of your commercial operation.

Its FAQ explicitly excludes controlled-substance prescribing, so define the intended program before assuming that a broad hormone category includes everything you plan to offer. Ask how your current checkout, recurring billing and support processes would connect to the quoted route. The strength is a focused clinical integration choice; the tradeoff is that your retained systems still need owners. Request complete economics and implementation work rather than comparing a consultation line item with a full platform package.

When is Healthie a different kind of alternative?

Healthie’s full web white-label option is an Enterprise software add-on. It belongs on the shortlist when your organization is evaluating practice software and already has, or will separately arrange, the clinical and operational resources needed to deliver care.

Do not compare an entry-level software subscription with the total cost of a staffed health brand. Ask for the exact Enterprise branding scope, integrations, provider requirements and responsibilities that remain outside the software agreement. The strength is a practice-software route with product customization; the tradeoff is the need to assemble the rest of the operation. It may be the right architecture for an established practice even when it is not a like-for-like replacement for a managed platform.

How do you switch without buying the same problem again?

Document the reason for leaving before signing another agreement. If the problem is slow support, test escalation ownership. If it is cost, model all charges at realistic volume. If it is product flexibility, demonstrate the exact change your current stack cannot support. A migration that preserves the underlying mismatch simply creates a new implementation bill.

For an existing patient base, use the patient migration checklist to plan records, upcoming care, orders and subscriptions separately. Request a sample export, field mapping and a small pilot with acceptance criteria. Cuvo’s published migration offer is evidence that migration is a shared market capability, not a unique TEHR feature. What matters is whether the new proposal handles your source data and continuity needs. Keep the current operation stable until the agreed test demonstrates that the transition works.

How should you compare setup deliverables?

Request an acceptance checklist for any proposed setup fee: configured storefront, approved integrations, trained staff and documented handoffs. Ask which existing assets will be reused and which will be rebuilt. This turns a large upfront number into a set of reviewable outputs. Compare those outputs with the internal work required by an API or software route before deciding that eliminating the setup fee necessarily reduces your implementation cost.

What is the next useful step?

Compare two or three written scopes against the operating brief you developed. Use TEHR vs Cuvo Health for the direct comparison, TEHR pricing for the commercial structure and a TEHR demo to test your own workflow. The resource library includes further implementation and procurement guides.

What else should you know?